Intervention Review

Anticholinergics for urinary symptoms in multiple sclerosis

  1. Richard S Nicholas1,*,
  2. Tim Friede2,
  3. Sally Hollis3,
  4. Carolyn A Young4

Editorial Group: Cochrane Multiple Sclerosis Group

Published Online: 21 JAN 2009

Assessed as up-to-date: 29 JAN 2008

DOI: 10.1002/14651858.CD004193.pub2

Database Title

Additional Information

How to Cite

Nicholas RS, Friede T, Hollis S, Young CA. Anticholinergics for urinary symptoms in multiple sclerosis. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD004193. DOI: 10.1002/14651858.CD004193.pub2.

Author Information

  1. 1

    Charing Cross Hospital, West London Neurosciences Centre, London, UK

  2. 2

    Warwick Medical School - University of Warwick, Health Sciences Research Institute, Coventry, UK

  3. 3

    University of Nottingham, c/o Cochrane Skin Group, Nottingham, UK

  4. 4

    The Walton Centre for Neurology and Neurosurgery, Liverpool, UK

*Richard S Nicholas, West London Neurosciences Centre, Charing Cross Hospital, Fulham Palace Road, London, W6 8RF, UK. richard.nicholas@btinternet.com.

Publication History

  1. Publication Status: New
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (59K)Standard (243K)Full (253K)

  1. Current Version

    Anticholinergics for urinary symptoms in multiple sclerosis

    Richard S Nicholas, Tim Friede, Sally Hollis and Carolyn A Young

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD004193.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Anticholinergics for urinary symptoms in multiple sclerosis

    RS Nicholas, T Friede, S Hollis and CA Young

    Article first published online: 8 OCT 2008 | DOI: 10.1002/14651858.CD004193

View Full Article (HTML) Summary (59K)Standard (243K)Full (253K)